| scholarly article | Q13442814 |
| P2093 | author name string | Reynaldo L Garcia | |
| Kenneth Anthony R Roquid | |||
| Krizelle Mae M Alcantara | |||
| P2860 | cites work | Suppression of PTEN expression by NF-kappa B prevents apoptosis | Q35544303 |
| Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer | Q35854235 | ||
| The mRNA related ceRNA-ceRNA landscape and significance across 20 major cancer types. | Q36676632 | ||
| The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications | Q37160617 | ||
| The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs | Q37497280 | ||
| Functions and Regulation of the PTEN Gene in Colorectal Cancer | Q38182985 | ||
| MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). | Q38303663 | ||
| PTEN ceRNA networks in human cancer. | Q38341492 | ||
| Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways. | Q38391347 | ||
| Identification of competing endogenous RNAs of the tumor suppressor gene PTEN: A probabilistic approach | Q38629675 | ||
| Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. | Q39095795 | ||
| Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma | Q39161179 | ||
| Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b | Q39584485 | ||
| c-Jun promotes cellular survival by suppression of PTEN. | Q40283457 | ||
| Identification of small RNA pathway genes using patterns of phylogenetic conservation and divergence | Q42584215 | ||
| 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer | Q42664000 | ||
| MicroRNA-transcription factor interactions and their combined effect on target gene expression in colon cancer cases | Q47332911 | ||
| PTEN promoter methylation in sporadic thyroid carcinomas | Q48645805 | ||
| Promoter methylation of the PTEN gene is a common molecular change in breast cancer | Q80403566 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis | Q24607462 | ||
| Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways | Q24624119 | ||
| An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma | Q24629145 | ||
| In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma | Q24629400 | ||
| Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs | Q24629589 | ||
| A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? | Q24629627 | ||
| A coding-independent function of gene and pseudogene mRNAs regulates tumour biology | Q24632651 | ||
| Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs | Q24635151 | ||
| The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 | Q24646996 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation | Q24655473 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Pten dose dictates cancer progression in the prostate | Q24791909 | ||
| Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample | Q24797157 | ||
| The multilayered complexity of ceRNA crosstalk and competition | Q27025671 | ||
| Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics | Q28088356 | ||
| DNMT1 and DNMT3b cooperate to silence genes in human cancer cells | Q28212826 | ||
| Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex | Q28244856 | ||
| Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells | Q28256740 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis | Q33778804 | ||
| The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression | Q33784365 | ||
| PTEN C-terminal deletion causes genomic instability and tumor development | Q33874805 | ||
| The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. | Q34470339 | ||
| A continuum model for tumour suppression | Q34631552 | ||
| Micro-RNAs meet epigenetics to make for better brains | Q34691332 | ||
| Subtle variations in Pten dose determine cancer susceptibility | Q35055350 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 544-558 | |
| P577 | publication date | 2019-12-20 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | Identification and validation of mRNA 3'untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN | |
| P478 | volume | 56 |
| Q100730224 | Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs | cites work | P2860 |
Search more.